Literature DB >> 27285318

Fundus autofluorescence imaging patterns in central serous chorioretinopathy according to chronicity.

W J Lee1, J-H Lee1, B R Lee1.   

Abstract

PurposeTo investigate the time-period characteristics associated with morphologic changes in central serous chorioretinopathy (CSC) using fundus autofluorescence (FAF).Patients and methodsRetrospective, cross-sectional observational case series. Patients were classified into three groups: acute and chronic according to the onset of subjective symptoms of 6 weeks and sequelae patients who have history and symptoms but no serous retinal detachment (SRD). We compared FAF images to obtain characteristic findings according to the chronicity.ResultsA total of 52 eyes were included in this study. Acute CSC eyes were characterized by decreased FAF intensity at the leakage point in 13/22 eyes (56.5%) and staining patterns with various levels of fluorescence signal (hyperautofluorescent (10 eyes, 43.5%), hypoautofluorescent (1 eye, 4.3%), and minimal changes (12 eyes, 52.2%)) in the area of SRD. In chronic CSC eyes, hyperautofluorescent (14 eyes, 63.6%) or minimal changes (8 eyes, 36.4%) were observed in the area of SRD. Discrete dots with increased FAF intensity were observed in chronic CSC eyes (P<0.001). Eyes with sequelae of CSC had mixed FAF patterns over areas of retinal pigment epithelium (RPE) atrophy in seven eyes (100%, P<0.001)) and descending tracts which showed various FAF intensities according to the RPE and photoreceptor status (P<0.001).ConclusionFAF imaging patterns in CSC eyes differ according to the course of the disease, reflecting RPE and outer retinal changes. Detailed investigation using FAF could help to estimate the duration of CSC and determine the proper treatment modality.

Entities:  

Mesh:

Year:  2016        PMID: 27285318      PMCID: PMC5136480          DOI: 10.1038/eye.2016.113

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  27 in total

1.  Acute central serous chorioretinopathy and fundus autofluorescence.

Authors:  Chiara M Eandi; Michael Ober; Reza Iranmanesh; Enrico Peiretti; Lawrence A Yannuzzi
Journal:  Retina       Date:  2005-12       Impact factor: 4.256

2.  Infrared fundus autofluorescence and central serous chorioretinopathy.

Authors:  Tetsuju Sekiryu; Tomohiro Iida; Ichiro Maruko; Kuniharu Saito; Takeshi Kondo
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-04-30       Impact factor: 4.799

3.  Subretinal dot-like precipitates and yellow material in central serous chorioretinopathy.

Authors:  Ichiro Maruko; Tomohiro Iida; Akira Ojima; Tetsuju Sekiryu
Journal:  Retina       Date:  2011-04       Impact factor: 4.256

4.  Abnormalities of fundus autofluorescence in central serous retinopathy.

Authors:  Andrea von Rückmann; Frederick W Fitzke; Joseph Fan; Anthony Halfyard; Alan C Bird
Journal:  Am J Ophthalmol       Date:  2002-06       Impact factor: 5.258

5.  Clinical factors related to visual outcome in central serous chorioretinopathy.

Authors:  Fabio B Aggio; Luiz Roisman; Gustavo B Melo; Daniel Lavinsky; José A Cardillo; Michel E Farah
Journal:  Retina       Date:  2010 Jul-Aug       Impact factor: 4.256

6.  Alterations of retinal pigment epithelium in central serous chorioretinopathy.

Authors:  Yasuhiko Hirami; Akitaka Tsujikawa; Manabu Sasahara; Norimoto Gotoh; Hiroshi Tamura; Atsushi Otani; Michiko Mandai; Nagahisa Yoshimura
Journal:  Clin Exp Ophthalmol       Date:  2007-04       Impact factor: 4.207

7.  Central serous chorioretinopathy in younger and older adults.

Authors:  R F Spaide; L Campeas; A Haas; L A Yannuzzi; Y L Fisher; D R Guyer; J S Slakter; J A Sorenson; D A Orlock
Journal:  Ophthalmology       Date:  1996-12       Impact factor: 12.079

8.  Fundus autofluorescence and central serous chorioretinopathy.

Authors:  Richard F Spaide; James M Klancnik
Journal:  Ophthalmology       Date:  2005-05       Impact factor: 12.079

9.  Subthreshold diode micropulse photocoagulation for the treatment of chronic central serous chorioretinopathy with juxtafoveal leakage.

Authors:  San-Ni Chen; Jiunn-Feng Hwang; Li-Fang Tseng; Chun-Ju Lin
Journal:  Ophthalmology       Date:  2008-12       Impact factor: 12.079

10.  Morphologic changes in acute central serous chorioretinopathy evaluated by fourier-domain optical coherence tomography.

Authors:  Hisataka Fujimoto; Fumi Gomi; Taku Wakabayashi; Miki Sawa; Motokazu Tsujikawa; Yasuo Tano
Journal:  Ophthalmology       Date:  2008-04-18       Impact factor: 12.079

View more
  16 in total

1.  Multimodal retinal imaging in central serous chorioretinopathy treated with oral eplerenone or photodynamic therapy.

Authors:  A Rabiolo; I Zucchiatti; A Marchese; G Baldin; R Sacconi; D Montorio; M V Cicinelli; L Querques; F Bandello; G Querques
Journal:  Eye (Lond)       Date:  2017-12-21       Impact factor: 3.775

2.  Imaging Characteristics of Neovascular and Atrophic Pachychoroidal Spectrum Diseases.

Authors:  Rui Hua; Meixia Zhang
Journal:  Front Med (Lausanne)       Date:  2022-07-04

3.  Interobserver Agreement of Novel Classification of Central Serous Chorioretinopathy.

Authors:  Niroj K Sahoo; Deepika C Parameshwarappa; Mahima Jhingan; Filippo Tatti; Claudio Iovino; Enrico Peiretti
Journal:  Cureus       Date:  2022-06-14

4.  Distinct characteristics of central serous chorioretinopathy according to gender.

Authors:  Seigo Yoneyama; Ayumi Fukui; Yoichi Sakurada; Nobuhiro Terao; Taiyo Shijo; Natsuki Kusada; Atsushi Sugiyama; Mio Matsubara; Yoshiko Fukuda; Wataru Kikushima; Ravi Parikh; Fumihiko Mabuchi; Chie Sotozono; Kenji Kashiwagi
Journal:  Sci Rep       Date:  2022-06-22       Impact factor: 4.996

5.  FUNDUS AUTOFLUORESCENCE PATTERNS IN CENTRAL SEROUS CHORIORETINOPATHY.

Authors:  Jisang Han; Nam Suk Cho; Kiyoung Kim; Eung Suk Kim; Do Gyun Kim; Joon Mo Kim; Seung-Young Yu
Journal:  Retina       Date:  2020-07       Impact factor: 3.975

6.  Central Serous Chorioretinopathy Analyzed by Multimodal Imaging.

Authors:  Liang Han; Jose Ronaldo Lima de Carvalho; Rait Parmann; Tongalp H Tezel; Stanley Chang; Tarun Sharma; Janet R Sparrow
Journal:  Transl Vis Sci Technol       Date:  2021-01-08       Impact factor: 3.283

Review 7.  The Role of Imaging in Planning Treatment for Central Serous Chorioretinopathy.

Authors:  Stefano Da Pozzo; Pierluigi Iacono; Alessandro Arrigo; Maurizio Battaglia Parodi
Journal:  Pharmaceuticals (Basel)       Date:  2021-01-29

8.  Fundus Autofluorescence and Optical Coherence Tomography Characteristics in Different Stages of Central Serous Chorioretinopathy.

Authors:  Mary Ho; Stephanie H W Kwok; Andrew C Y Mak; Frank H P Lai; Danny S C Ng; Li Jia Chen; Lawrence P Iu; Alvin L Young; Marten Brelen
Journal:  J Ophthalmol       Date:  2021-05-31       Impact factor: 1.909

Review 9.  Central serous chorioretinopathy: Current update on pathophysiology and multimodal imaging.

Authors:  George Joseph Manayath; Ratnesh Ranjan; Vanee Sheth Shah; Smita S Karandikar; Veerappan R Saravanan; Venkatapathy Narendran
Journal:  Oman J Ophthalmol       Date:  2018 May-Aug

10.  Efficacy of nanosecond laser treatment in central serous chorioretinopathy with and without atrophy of retinal pigment epithelium.

Authors:  Hakan Kaymak; Saskia Funk; Andreas Fricke; Roxana Fulga; Karsten Klabe; Berthold Seitz; Achim Langenbucher; Hartmut Schwahn
Journal:  Int J Retina Vitreous       Date:  2020-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.